BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 27
• 30
• 31

• Drug Development

  Selecta Biosciences, Inc. Announces Successful Pre-Clinical Study Of SEL-201 As An Antigen-Specific Immune Tolerance Treatment For Patients Receiving Factor VIII Therapy

  December 9, 2013

   · 

  1 min read
• Biotech Beach

  Agendia Announces Presentation Of Data Highlighting Symphony Suite Of Genomic Tests (MammaPrint, BluePrint, and TargetPrint) At San Antonio Breast Cancer Symposium

  December 9, 2013

   · 

  1 min read
• Genetown

  Idenix Pharmaceuticals, Inc. Announces Declaration Of Senior Party In A Second Patent Interference By The USPTO

  December 9, 2013

   · 

  1 min read
• Mazor Robotics Expands Its Foothold In North America

  December 9, 2013

   · 

  1 min read
• Biotech Bay

  Agilent Technologies, Inc. (Santa Clara, California) To Sponsor Life Science Workshops In San Diego, San Francisco Bay Area On Dec. 11 And 12

  December 9, 2013

   · 

  1 min read
• BioCapital

  MaxCyte, Inc. Presents Data On Stable Cell Line Generation And Rapid, High Titer Production Of Antibodies And Proteins Using Flow Electroporation

  December 9, 2013

   · 

  1 min read
• Drug Development

  Gilead Sciences, Inc. Announces Pivotal Phase 2 Data For Idelalisib In Refractory Indolent Non-Hodgkin’s Lymphoma

  December 9, 2013

   · 

  1 min read
• Business

  Getinge Appoints Harald F. Stock As New President And CEO Of Arjohuntleigh And Executive Vice President Extended Care Business Area

  December 9, 2013

   · 

  1 min read
• Bio NC

  Biologics, Inc. (NC) Announces Collaborative Program Partnership For YERVOY® (Ipilimumab) Patients

  December 9, 2013

   · 

  1 min read
• Pharm Country

  Actinium Pharmaceuticals, Inc. Release: Encouraging Clinical Data From Multicenter Phase 1/2 Trial On Actinium’s Actimab-A Presented At American Society of Hematology Annual Meeting

  December 9, 2013

   · 

  3 min read